TERAPIA CELULAR Y MEDICINA REGENERATIVA
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milán, ItaliaPublicaciones en colaboración con investigadores/as de Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (6)
2023
-
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 15, pp. 2827-2842
2021
-
Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes
American Journal of Hematology
-
Phase III, Randomized, Placebo-Controlled Trial of CC-486 (Oral Azacitidine) in Patients With Lower-Risk Myelodysplastic Syndromes
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 13, pp. 1426-1436
2018
-
Giant-cell tumor of the rib cage extending to the spine: Case report
Orthopade, Vol. 47, Núm. 5, pp. 437-441
-
Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation
Biology of Blood and Marrow Transplantation, Vol. 24, Núm. 11, pp. 2365-2370
2015
-
Finite element analysis and cadaveric cinematic analysis of fixation options for anteriorly implanted trabecular metal interbody cages
European Spine Journal, Vol. 24, pp. 918-923